Clinical Significance of HER2 Overexpression in Gastric and Gastroesophageal Junction Cancers. (Q53424338)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26179664%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

title

Clinical Significance of HER2 Overexpression in Gastric and Gastroesophageal Junction Cancers (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26179664%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26179664%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Umut Demirci

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26179664%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

author name string

Meltem Baykara

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26179664%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Ozgur Ekinci

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26179664%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Sultan Cigdem Irkkan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26179664%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Halit Karaca

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26179664%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Muhammed Bulent Akinci

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26179664%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Olcun Umit Unal

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26179664%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Faysal Dane

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26179664%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Fatma Paksoy Turkoz

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26179664%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Ozan Balakan

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26179664%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Eylem Pinar Eser

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26179664%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Selcuk Cemil Ozturk

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26179664%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Metin Ozkan

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26179664%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Berna Oksuzoglu

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26179664%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Alper Sevinc

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26179664%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Necla Demir

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26179664%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Hakan Harputluoglu

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26179664%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Bulent Yalcin

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26179664%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Ugur Coskun

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26179664%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Aytug Uner

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26179664%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Ahmet Ozet

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26179664%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Suleyman Buyukberber

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26179664%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Anatolian Society of Medical Oncology (ASMO)

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26179664%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

publication date

16 July 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26179664%20AND%20SRC:MED&resulttype=core&format=json

Journal of Gastrointestinal Surgery

19 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26179664%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26179664%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

page(s)

1565-1571

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26179664%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26179664%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11605-015-2888-y

19 February 2020

exact match

0 references

cites work

The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities

1 reference

https://api.crossref.org/works/10.1007%2FS11605-015-2888-Y

Epidermal growth factor receptor family tyrosine kinases as signal integrators and therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-015-2888-Y

HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-015-2888-Y

Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIalpha gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-015-2888-Y

Assessment of a HER2 scoring system for gastric cancer: results from a validation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-015-2888-Y

HER-2 amplification is highly homogenous in gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-015-2888-Y

HER-2/neu amplification is an independent prognostic factor in gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-015-2888-Y

Association of ERBB2 gene status with histopathological parameters and disease-specific survival in gastric carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-015-2888-Y

Overexpression of Grb2/HER2 signaling in Chinese gastric cancer: their relationship with clinicopathological parameters and prognostic significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-015-2888-Y

Prognosis of HER2 over-expressing gastric cancer patients with liver metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-015-2888-Y

HER2/neu testing for anti-HER2-based therapies in patients with unresectable and/or metastatic gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-015-2888-Y

Prognosis of metastatic gastric and gastroesophageal junction cancer by HER2 status: a European and USA International collaborative analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-015-2888-Y

HER2 as a Prognostic Marker in Gastric Cancer - A Systematic Analysis of Data from the Literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-015-2888-Y

Clinicopathologic features and treatment outcomes of patients with human epidermal growth factor receptor 2-positive adenocarcinoma of the esophagus and gastroesophageal junction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-015-2888-Y

Prognosis of patients with advanced gastric cancer by HER2 status and trastuzumab treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-015-2888-Y

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-015-2888-Y

Gastric cancer: trastuzumab trial results spur search for other targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-015-2888-Y

Differences in HER2 over-expression between proximal and distal gastric cancers in the Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-015-2888-Y

Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-015-2888-Y

c-erb B-2 expression is associated with tumor location and venous invasion and influences survival of patients with gastric carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-015-2888-Y

Prognostic significance of HER2/neu expression in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-015-2888-Y

Overexpression of c-erbB-2 protein in gastric cancer. Its correlation with long-term survival of patients

21 January 2018

1 reference

12 December 2020

Expression of epidermal growth factor receptors on normal human gastric epithelia and gastric carcinomas

1 reference

12 December 2020

c-erbB-2 is of independent prognostic relevance in gastric cancer and is associated with the expression of tumor-associated protease systems

1 reference

12 December 2020

HER2 expression in gastric cancer: Rare, heterogeneous and of no prognostic value - conclusions from 924 cases of two independent series.

1 reference

12 December 2020

HER2 expression and its clinicopathological features in resectable gastric cancer

1 reference

12 December 2020

Clinicopathological significance of c-erbB-2 protein expression in human gastric carcinoma

1 reference

12 December 2020

Evaluation of immunoreactivity for erbB-2 protein as a marker of poor short term prognosis in gastric cancer

1 reference

12 December 2020

An immunohistochemical study of c-erbB-2 protein in gastric carcinomas and lymph-node metastases: is the c-erbB-2 protein really a prognostic indicator?

1 reference

12 December 2020

Evaluation of HER2 protein expression in gastric carcinomas: comparative analysis of 1,414 cases of whole-tissue sections and 595 cases of tissue microarrays

1 reference

12 December 2020

erbB-2 expression in well-differentiated adenocarcinoma of the stomach predicts shorter survival after curative resection

1 reference

12 December 2020

Expression of ERBB2 in human gastric carcinomas: relationship between p185ERBB2 expression and the gene amplification

1 reference

12 December 2020

The prognostic significance of amplification and overexpression of c-met and c-erb B-2 in human gastric carcinomas

1 reference

12 December 2020

Human epidermal growth factor receptor 2 testing in gastroesophageal cancer: correlation between immunohistochemistry and fluorescence in situ hybridization

1 reference

12 December 2020

Comparative study on overexpression of HER2/neu and HER3 in gastric cancer

1 reference

12 December 2020

Double immunostaining for c-erbB-2 and p53 in human stomach cancer cells

1 reference

12 December 2020

Overexpression of c-ErbB-2 protein in gastric cancer by immunohistochemical stain

1 reference

12 December 2020

The prognostic significance of HER2 positivity for advanced gastric cancer patients undergoing first-line modified FOLFOX-6 regimen

1 reference

12 December 2020

Trastuzumab inhibits the growth of human gastric cancer cell lines with HER2 amplification synergistically with cisplatin.

1 reference

12 December 2020

Relationship of C-erbB-2 protein expression and gene amplification to invasion and metastasis in human gastric cancer

1 reference

12 December 2020

10.1007/S11605-015-2888-Y

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26179664%20AND%20SRC:MED&resulttype=core&format=json

release_mmgi3va3ljhzdgkbg7d5dvuxf4

19 February 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mmgi3va3ljhzdgkbg7d5dvuxf4

24 November 2022

mapped directly with Wikidata item

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26179664%20AND%20SRC:MED&resulttype=core&format=json